Core a
The specific aims of the resource for Clinical Studies of AKI (Core A) are to:
Clinical Core plans to use existing data repositories and biospecimens as well as new data from EHR and Biospecimens linked to EHR data.(1): Provide access to clinical data of patients at risk for or with AKI and consultation for their use.
(1a): Provide consultation and access to curated clinical data from prior clinical studies hosted by Core A.
(1b): Provide access to new harmonized real-world data from the EHR to novel clinical research.
(1a): Provide consultation and access to curated clinical data from prior clinical studies hosted by Core A.
(1b): Provide access to new harmonized real-world data from the EHR to novel clinical research.
(2): Provide access to biospecimens of patients at risk for or with AKI and consultation for their use.
(2a): Provide consultation and access to biospecimens from prior studies hosted by Core A.
(2b): Provide a novel platform to link biospecimens of patients at risk for or with AKI with EHR data.
(2a): Provide consultation and access to biospecimens from prior studies hosted by Core A.
(2b): Provide a novel platform to link biospecimens of patients at risk for or with AKI with EHR data.
Biomedical Resource Clinical Care supports:
- Bioinformatics Resources: Jake Chen, PhD, Jin Chen, PhD & Jejo Koola, MD, MS
- Biostatistical Resources: Ashutosh Tamhane, PhD & Gary Cutter, PhD
- Clinical Trial Resources: Lama Ghazi, MD, PhD & Joachim Ix, MD
- Biorepository Resources: Frida Rosenblum, MD
Clinical Core Resources and Service Charges
Core Leadership
